Correction
Repligen adding former Motorola plant in MA to filtration footprint
Repligen has leased a 64,000 square-foot facility in Massachusetts to where it will transfer production of its TangenX filtration products .
Archives for February 13, 2018
Horizon licenses ‘copy and paste’ tech to optimise commercial cell line
Horizon’s gene editing technology will be used by a US immuno-oncology firm to make a cell line for commercial use.
Celltrion FDA warning causes headache for Teva’s biologics ambition
A warning letter at manufacturing partner Celltrion could delay approvals of the potential migraine prevention monoclonal antibody fremanezumab and two biosimilar candidates, says Teva.